Hollencrest Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.68K | Hold |
7
| – | – | ﹤0.01% | 874 |
|
|
2025
Q1 | $4.44K | Sell |
7
-1
| -13% | -$635 | ﹤0.01% | 861 |
|
|
2024
Q4 | $5.7K | Hold |
8
| – | – | ﹤0.01% | 821 |
|
|
2024
Q3 | $8.41K | Buy |
8
+1
| +14% | +$1.05K | ﹤0.01% | 761 |
|
|
2024
Q2 | $7.36K | Sell |
7
-100
| -93% | -$105K | ﹤0.01% | 749 |
|
|
2024
Q1 | $103K | Sell |
107
-232
| -68% | -$223K | ﹤0.01% | 362 |
|
|
2023
Q4 | $298K | Sell |
339
-13
| -4% | -$11.4K | 0.03% | 247 |
|
|
2023
Q3 | $290K | Hold |
352
| – | – | 0.03% | 234 |
|
|
2023
Q2 | $253K | Hold |
352
| – | – | 0.03% | 263 |
|
|
2023
Q1 | $289K | Buy |
352
+345
| +4,929% | +$283K | 0.03% | 238 |
|
|
2022
Q4 | $5.05K | Buy |
+7
| New | +$5.05K | ﹤0.01% | 826 |
|